Alopexx, Inc. (ALPX)

Alopexx will go public soon. The estimated IPO date is February 15, 2023.
IPO Price
$5.00
Shares Offered
3,000,000
Deal Size
$15.00M
Chart not available yet
Data will show when the stock starts trading on Feb 15, 2023.
Market Cap 39.26M
Revenue (ttm) n/a
Net Income (ttm) -956,954
Shares Out 7.85M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About ALPX

Alopexx is a clinical stage biotechnology company developing novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal, and parasitic infections that express the antigenic target poly N-acetyl glucosamine (PNAG). To date over 75 separate pathogens have been found to express PNAG. While the ultimate decision on the safety and efficacy of our therapeutics will be determined by the FDA and other health authorities, it is our management’s assessment that the broad-spectrum potential of our therapeutics will allow t... [Read more]

Industry Health Care
IPO Date Feb 15, 2023
Country United States
Stock Exchange NASDAQ
Ticker Symbol ALPX
Full Company Profile

Financial Performance

Financial Statements

News

Will Alopexx (ALPX) Stock Be the Next Hot IPO?

Alopexx (NASDAQ: ALPX) is the newest member of the Nasdaq, as the clinical-stage biotechnology company held its initial public offering today. The company has a focus on developing therapies to treat...

4 months ago - InvestorPlace